PTFE Vascular Graft Surface Modification for Endothelialization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Hydrophobic surfaces in vascular grafts face challenges in promoting endothelial cell affinity and antithrombogenicity due to the lack of bioactive binding sites, leading to high risks of thrombosis and slow endothelialization, which existing modification methods like plasma treatment and heparin incorporation are insufficient in addressing.
Innovation Solution
A method involving oxygen plasma treatment of hydrophobic surfaces followed by dopamine coating and subsequent immobilization of bioactive molecules such as RGD and heparin using a polymer coating, specifically polyethylenimine, to enhance cell attachment and reduce thrombogenicity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If plasma treatment is used to improve endothelial cell affinity, then cell adhesion is enhanced, but the introduced hydrophilic groups are not stable long-term
Solution Approach 1:
The patent applies preliminary action by first treating the PTFE surface with oxygen plasma to introduce hydrophilic groups, then immediately coating with dopamine while the surface is still activated. This sequential approach ensures that the hydrophilic groups are stabilized through covalent bonding with dopamine before they can degrade or leach, resolving the contradiction between initial cell affinity and long-term stability
Solution Approach 2:
The patent creates a composite surface structure combining PTFE base material with dopamine coating layer. This composite approach allows the PTFE to maintain its bulk mechanical properties while the dopamine surface layer provides stable hydrophilic groups for long-term endothelial cell affinity, thus resolving the contradiction between material stability and surface bioactivity
2Object-affected harmful factors
If heparin is incorporated to improve antithrombogenicity, then platelet adhesion is reduced, but heparin molecules gradually release into blood flow causing low sustainability
Solution Approach 1:
The patent uses dopamine as an intermediary layer between the PTFE surface and heparin. The dopamine coating provides stable covalent bonding sites that anchor heparin molecules firmly to the surface, preventing their gradual release into blood flow. This intermediary structure maintains sustained antithrombogenicity by keeping heparin bound to the graft surface throughout implantation
Solution Approach 2:
The patent changes the chemical state of heparin from a freely dissolved molecule to a covalently bound surface-modified molecule. By incorporating heparin into the dopamine-coated PTFE surface through covalent bonding, the heparin transitions from a soluble, leachable form to an immobilized, sustained-release form, resolving the contradiction between immediate antithrombogenic effect and long-term sustainability
3Strength
If hydrophobic materials are used for SDVGs, then mechanical strength is maintained, but endothelial cell affinity is poor leading to slow endothelialization
Solution Approach 1:
The patent applies local quality by modifying only the surface properties of the PTFE material while leaving the bulk material unchanged. The oxygen plasma treatment and dopamine coating are confined to the surface layer, providing hydrophilic and bioactive properties locally at the cell-contact interface, while the bulk PTFE maintains its mechanical strength and structural integrity
Solution Approach 2:
The patent transitions from modifying the bulk material properties to modifying the surface dimension. By applying surface coatings and treatments only to the outer layer of the PTFE graft, the invention creates a multi-dimensional structure where the surface dimension provides endothelial cell affinity and the bulk dimension provides mechanical strength, resolving the contradiction between these two requirements
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method significantly improves endothelial cell affinity and antithrombogenicity by increasing hydrophilicity and surface roughness, reducing platelet adhesion, and promoting rapid endothelialization, as demonstrated by improved cell viability and proliferation on modified surfaces.
Implementation Method 1
treating the hydrophobic surface with oxygen plasma to form an oxygen plasma-treated surface
Implementation Method 2
coating the oxygen plasma-treated surface with a solution comprising dopamine to form a dopamine-coated surface
Implementation Method 3
coating the dopamine-coated surface with a solution comprising polymer comprising a terminal amine to form a polymer coating on the dopamine-coated surface
Data Source
AI summary
Disclosed herein are methods for modifying a substrate having a hydrophobic surface. Also disclosed are modified hydrophobic substrates. The modified hydrophobic substrates and methods disclosed herein advantageously improve cell affinity and antithrombogenicity of hydrophobic surfaces.